Related Experiment Videos
Epidemiology of meningococcal disease in Denmark 1980-1988
S Samuelsson1, S Gustavsen, T Rønne
1Department of Epidemiology, Statens Seruminstitut, Copenhagen, Denmark.
Abstract:
Based on epidemiological data of notified cases of meningococcal disease (MD) in Denmark during the period 1980-88 the recommendations for prophylaxis are evaluated. In 1986 the incidence of MD increased about 60% to 5.5 per 100,000 population. The clinical diagnosis of MD was verified by culture of Neisseria meningitidis in 79% of notified cases. About 40% of all patients were less than 4 years of age. The mortality in 1988 was found to be 10%. Serogroup B disease accounted for about 80% of the cases. Two co-primary and 28 secondary cases were registered. Two major outbreaks of serogroup C disease occurred in 1984 and 1986, respectively. In small clusters of 2-3 cases within socially well-defined groups the recommendations for prophylaxis are sufficient. But for the new pattern of clusters spread over months to years in certain geographical areas or open social groups, especially among teenagers, the existing recommendations are insufficient. The occurrence of localized clusters of serogroup B disease emphasises the need for a vaccine against serogroup B disease.
Insights
Epidemiological data reveal that current meningococcal disease (MD) prophylaxis recommendations are insufficient for widespread, long-term clusters, particularly in teenagers. The study highlights the urgent need for a serogroup B vaccine due to localized outbreaks.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Meningococcal disease (MD) poses a significant public health challenge.
- Epidemiological trends in Denmark from 1980-1988 provide insights into disease patterns and prophylaxis effectiveness.
- An increase in MD incidence was observed in 1986.
Purpose of the Study:
- To evaluate the efficacy of current prophylaxis recommendations for meningococcal disease based on Danish epidemiological data.
- To identify gaps in prophylaxis strategies for emerging patterns of MD clusters.
- To underscore the need for a serogroup B vaccine.
Main Methods:
- Analysis of epidemiological data from notified cases of meningococcal disease in Denmark (1980-1988).
- Verification of clinical diagnoses through Neisseria meningitidis cultures.
- Examination of disease incidence, age distribution, mortality, serogroup prevalence, and cluster patterns.
Main Results:
- Meningococcal disease incidence rose by 60% in 1986, reaching 5.5 per 100,000 population.
- Neisseria meningitidis confirmed 79% of notified MD cases; 40% of patients were under 4 years old.
- Serogroup B accounted for 80% of cases, with localized clusters observed, emphasizing the need for a vaccine. Existing prophylaxis is insufficient for widespread, long-term clusters, especially among teenagers.
Conclusions:
- Current meningococcal disease prophylaxis recommendations are adequate for small, well-defined clusters but insufficient for widespread, prolonged outbreaks.
- The emergence of localized serogroup B clusters highlights a critical need for a targeted vaccine.
- Public health strategies must adapt to evolving patterns of meningococcal disease transmission.